Tazarotenedrug info
tazarotene 0.001 MG/MG Topical Gel
What it is used for
Trilitas™ gel, 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis of up to 20% body surface area involvement. Trilitas™ gel, 0.1% is indicated for the topical treatment of mild to moderate facial acne vulgaris. Limitations of Use The safety of Trilitas™ gel use on more than 20% body surface area has not been established.
1.1 Plaque Psoriasis
Trilitas™ (tazarotene) gel, 0.1% is indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement.
1.2 Acne Vulgaris
Trilitas™ (tazarotene) gel, 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. The efficacy of Trilitas™ gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established.
1.3 Limitations of
Use The safety of Trilitas™ gel use on more than 20% body surface area has not been established in psoriasis or acne.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective May 18, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Trilitas™ (tazarotene) gel, 0.1% is for topical use and contains the active ingredient, tazarotene. Each gram of Trilitas™ gel, 0.1% contains 1 mg of tazarotene in a clear to yellow translucent, aqueous gel. Tazarotene is a member of the acetylenic class of retinoids. Chemically, tazarotene is ethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate. The compound has an empirical formula of C 21 H 21 NO 2 S and molecular weight of 351.46. The structural formula is shown below: Trilitas™ gel contains the following inactive ingredients: benzyl alcohol 1%; ascorbic acid; butylated hydroxyanisole; butylated hydroxytoluene; carbomer homopolymer type B; edetate disodium; hexylene glycol; poloxamer 407; polyethylene glycol 400; polysorbate 40; purified water; and tromethamine. Chemical Structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective May 18, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance